|
Araneta, Maria Rosario Gorrez |
University Of California, San Diego |
12/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
DPPOS Study |
PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
|
Bae-Jump, Victoria Lin |
Univ Of North Carolina Chapel Hill |
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer |
|
PA-17-073: Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies |
|
Barroilhet, Lisa M |
University Of Wisconsin-Madison |
Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Boyer, Thomas G |
University Of Texas Hlth Science Center |
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids |
|
PAR-18-830: The Role of Epitranscriptomics in Development and Disease |
|
Bride, Colleen M Mc |
Emory University |
Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and their Close Relatives to Consider Genetic Services |
|
PAR-18-616: Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach |
|
Brown, Angela |
Washington University |
17/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
DPPOS Study |
RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers |
|
Brown, Kristy |
Weill Medical Coll Of Cornell Univ |
Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors |
|
RFA-CA-15-008: Research Answers to NCI's Provocative Questions |
|
Castle, Philip E |
Albert Einstein College Of Medicine |
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical-Cancer Risk Reduction in HIV+ Women living in Mozambique |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Chibwesha, Carla J |
Univ Of North Carolina Chapel Hill |
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Crandall, Jill P |
Albert Einstein College Of Medicine |
20/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Clinical Center |
DPPOS Study |
RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers |
|
Crew, Katherine D |
Columbia University Health Sciences |
Multicenter trial of decision support for breast cancer chemoprevention |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Dabelea, Dana |
University Of Colorado Denver |
6/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
DPPOS Study |
RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers |
|
Dagogo-Jack, Samuel |
University Of Tennessee Health Sci Ctr |
9/22 Limited Competition for Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center |
DPPOS Study |
RFA-DK-20-501: Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers |
|
Degnim, Amy C |
Mayo Clinic Rochester |
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Dryden-Peterson, Scott Lee |
Brigham And Women'S Hospital |
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
